Hospitalisation patterns of patients with interstitial lung disease in the light of comorbidities and medical treatment – a German claims data analysis

被引：0
|
作者：
Julia Wälscher
Sabine Witt
Larissa Schwarzkopf
Michael Kreuter
机构：
[1] University of Heidelberg,Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Critical Care Medicine, Thoraxklinik
[2] Member of the German Center for Lung Research (DZL),undefined
[3] Institute of Health Economics and Health Care Management,undefined
[4] Helmholtz Zentrum München (GmbH) - German Research Center for Environmental Health,undefined
[5] Comprehensive Pneumology Center Munich (CPC-M),undefined
[6] Member of the German Center for Lung Research (DZL),undefined
来源：
Respiratory Research | / 21卷
关键词：
Interstitial lung disease; Hospitalisation; Comorbidity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Patterns of Interstitial Lung Disease During Everolimus Treatment in Patients with Metastatic Renal Cell Carcinoma
    Mizuno, Ryuichi
    Asano, Koichiro
    Mikami, Shuji
    Nagata, Hirohiko
    Kaneko, Gou
    Oya, Mototsugu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (05) : 442 - 446
  • [42] Autoimmune comorbidities in patients with metastatic melanoma: a retrospective analysis of us claims data
    Qiufei Ma
    Mark Shilkrut
    Zhongyun Zhao
    Minming Li
    Nicolas Batty
    Beth Barber
    BMC Cancer, 18
  • [43] Treatment Initiation in Patients with Interstitial Lung Disease in Canada
    Assayag, Deborah
    Garlick, Kristopher
    Johannson, Kerri A.
    Fell, Charlene D.
    Kolb, Martin
    Cox, Gerard
    Hambly, Nathan
    Manganas, Helene
    Morisset, Julie
    Fisher, Jolene H.
    Shapera, Shane
    Gershon, Andrea S.
    To, Teresa
    Sadatsafavi, Mohsen
    Wilcox, Pearce G.
    Halayko, Andrew J.
    Khalil, Nasreen
    Ryerson, Christopher J.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (10) : 1661 - 1668
  • [44] Disparities in the Treatment of Patients with Interstitial Lung Disease in Canada
    Assayag, D.
    Garlick, K.
    Johannson, K. A.
    Fell, C. D.
    Kolb, M. R. J.
    Cox, G. P.
    Hambly, N.
    Manganas, H.
    Morisset, J.
    Fisher, J. H.
    Shapera, S.
    Sadatsafavi, M.
    Wilcox, P.
    Halayko, A. J.
    Khalil, N.
    Ryerson, C. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [45] Interstitial lung disease in patients with scleroderma - Treatment with rituximab
    A Muñoz
    R Martínez
    S Rodríguez
    M L Velloso
    J L Marenco
    Journal of Translational Medicine, 8 (Suppl 1)
  • [46] Survival analysis in lung cancer patients with interstitial lung disease
    Alomaish, Hassan
    Ung, Yee
    Wang, Stella
    Tyrrell, Pascal N.
    Zahra, Saly Abo
    Oikonomou, Anastasia
    PLOS ONE, 2021, 16 (09):
  • [47] INTERSTITIAL LUNG DISEASE IN PATIENTS WITH SCLERODERMA: TREATMENT WITH RITUXIMAB
    Munoz, A.
    Martinez, R.
    Leon, M.
    Gallo, F.
    Velloso, M. L.
    Rodriguez, S.
    Mayordomo, L.
    Rejon, E.
    Marenco, J. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 : A78 - A78
  • [48] Adjudicating serious liver injury/disease and interstitial lung disease in electronic health records or claims data
    Tave, Arlene K.
    Goehring, Earl, Jr.
    Desai, Vibha
    Wu, Chuntao
    Bohn, Rhonda
    Shara, Nawar
    Tamayo, Sally
    Sicignano, Nicholas
    Juhaeri, Juhaeri
    Jones, Judith K.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 119 - 119
  • [49] A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease
    Wong, Alyson W.
    Lee, Tae Yoon
    Johannson, Kerri A.
    Assayag, Deborah
    Morisset, Julie
    Fell, Charlene D.
    Fisher, Jolene H.
    Shapera, Shane
    Gershon, Andrea S.
    Cox, Gerard
    Halayko, Andrew J.
    Hambly, Nathan
    Manganas, Helene
    Sadatsafavi, Mohsen
    Wilcox, Pearce G.
    To, Teresa
    Marcoux, Veronica
    Khalil, Nasreen
    Kolb, Martin
    Ryerson, Christopher J.
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [50] A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease
    Alyson W. Wong
    Tae Yoon Lee
    Kerri A. Johannson
    Deborah Assayag
    Julie Morisset
    Charlene D. Fell
    Jolene H. Fisher
    Shane Shapera
    Andrea S. Gershon
    Gerard Cox
    Andrew J. Halayko
    Nathan Hambly
    Helene Manganas
    Mohsen Sadatsafavi
    Pearce G. Wilcox
    Teresa To
    Veronica Marcoux
    Nasreen Khalil
    Martin Kolb
    Christopher J. Ryerson
    Respiratory Research, 21
12345